Tesla Motors Inc (NASDAQ:TSLA)’s planned gigafactory may be bringing more and more risks along with it, and as a result, Wedbush analysts have reduced their price target on the automaker’s stock. They have maintained their Outperform rating, however. Tesla Motors Inc (NASDAQ:TSLA) stock opened today at $212.80 and is currently trading at $213.43. The stock showed a negative weekly performance of -11.74%.
The Micron Technology, Inc. (NASDAQ:MU) on Mar. 27 announced their platinum membership with the OpenPOWER Foundation, an open development community based on the POWER microprocessor architecture. Micron joins a growing roster of technology organizations working collaboratively to build advanced server, networking, storage and acceleration technology. The OpenPOWER Foundation also works with industry-leading open source software aimed at delivering more choice, control and flexibility to developers of next-generation, hyperscale and cloud data centers. Micron Technology, Inc. (NASDAQ:MU) stock opened at $21.99, in current trading session and currently is at $22.21, by loosing –0.13%.The 52 week range of $9.04-$25.68. Company’s market capitalization is $23.56 billion.
The MannKind Corporation (NASDAQ:MNKD) on Feb. 18 reported financial results for the fourth quarter and full year ended December 31, 2013. The net loss applicable to common stockholders for fiscal year 2013 was $(191.5) million, or $(0.64) per share based on 299.6 million weighted average shares outstanding, compared with a net loss applicable to common stockholders of $(169.4) million, or $(0.94) per share based on 180.9 million weighted average shares outstanding for fiscal year 2012.MannKind Corporation (NASDAQ:MNKD) stock is currently trading at $5.59 .The EPS of the stock is -0.64. Company’s market capitalization is $2.09 billion.
Shares of Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) are up 7% in premarket trading on rumors that Jazz Pharmaceuticals (JAZZ) is mulling a buyout for as much as $20/share versus yesterday’s close of $7.60. This would value the acquisition at ~$3.6B.Consensus 2014 and 2015 revenue estimates for ARIA are $87.9M and $158.4M, respectively.287 mutual funds own ARIA, down from 505 a year earlier. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened the session at $8.04, and now is at $8.08. The 52 week range of the ARIA stock remained $2.15-$23.00 and the day range was $7.92-$8.19.
Leave a Reply